Table 3.
Clinical characteristics of medically treated patients with IMH (good outcomes versus adverse outcomes)
| Good outcomes (n = 15) | Adverse Outcomes (n = 10) | p | |
|---|---|---|---|
| Age, yr (mean±SD) | 66.3±12.2 | 79.7±11.6 | 0.01* |
| Sex (female: male), %, n | 33.3:66.7 | 70:30 | 0.1 |
| 5:10 | 7:3 | ||
| Hypertension, %, n | 71.4 (11) | 60 (6) | 0.7 |
| Diabetes, %, n | 13.3 (2) | 10 (1) | 1.0 |
| Ischemic heart disease, %, n | 0 (0) | 10 (1) | 0.4 |
| Pleural effusion, %, n | 26.7 (4) | 10 (1) | 0.6 |
| Pericardial effusion, %, n | 53.3 (8) | 70 (7) | 0.7 |
| Cardiac tamponade, %, n | 0 (0) | 40 (4) | 0.02* |
| Mean systolic blood pressure, mm Hg | 161.4±54 | 124.8±35.9 | 0.07* |
| Mean hemoglobin, g/dL | 14.3±2.8 | 11±1.5 | 0.002* |
| Mean creatinine, μmol/L | 159.7±50.3 | 154.4±46.7 | 0.8 |
| Maximum aortic diameter, cm | 4.15±0.42 | 4.97±0.8 | 0.003* |
| Maximum hematoma thickness, mm | 11.6±6.4 | 11.5±5.7 | 0.95 |
| Concomitant involvement of descending aorta, %, n | 66.7 (10) | 90 (9) | 0.35 |
*
for p< 0.05